Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2019-01-02 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MAULEVRIER (49360), Maine-et-Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DU PARC : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU PARC is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MAULEVRIER (49360),
this company of category PME
shows in 2023 a revenue of 3.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU PARC (SIREN 844999177)
Indicator
2025
2024
2023
2022
2021
2020
Revenue
N/C
N/C
3 832 599 €
N/C
N/C
N/C
Net income
429 907 €
381 192 €
358 626 €
361 362 €
344 490 €
224 238 €
EBITDA
N/C
N/C
502 148 €
N/C
N/C
N/C
Net margin
N/C
N/C
9.4%
N/C
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE DU PARC generates positive net income of 430 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 224 k€ -> 430 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
429 907 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 95%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
95.484%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
45.731%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU PARC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Debt ratio
501.544
241.567
182.92
142.198
108.242
95.484
Financial autonomy
13.836
25.83
31.964
37.145
42.706
45.731
Repayment capacity
None
None
None
4.353
None
None
Cash flow / Revenue
None%
None%
None%
9.586%
None%
None%
Sector positioning
Debt ratio
95.482025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of SELARL PHARMACIE DU PARC (95.48) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
45.73%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of SELARL PHARMACIE DU PARC (45.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.35 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of SELARL PHARMACIE DU PARC (4.35) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 233.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
233.523
Liquidity indicators evolution SELARL PHARMACIE DU PARC
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
2025
Liquidity ratio
122.132
153.595
189.869
205.113
211.242
233.523
Interest coverage
None
None
None
3.538
None
None
Sector positioning
Liquidity ratio
233.522025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+12 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE DU PARC (233.52) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
3.54x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of SELARL PHARMACIE DU PARC (3.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DU PARC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
289 361 €
0 €
0 €
Inventory turnover (days)
0
0
0
23
0
0
Customer payment term (days)
139
137
183
6
0
0
Supplier payment term (days)
1015
619
534
30
0
0
Positioning of SELARL PHARMACIE DU PARC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DU PARC is estimated at
6 829 123 €
(range 4 634 275€ - 10 715 835€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
4634k€6829k€10715k€
6 829 123 €Range: 4 634 275€ - 10 715 835€
NAF 5 année 2025
Valuation method used
Net Income Multiple
429 907 €
×
15.9x
=6 829 124 €
Range: 4 634 276€ - 10 715 836€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU PARC with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU PARC
What is the revenue of SELARL PHARMACIE DU PARC ?
The revenue of SELARL PHARMACIE DU PARC in 2023 is 3.8 M€.
Is SELARL PHARMACIE DU PARC profitable?
Yes, SELARL PHARMACIE DU PARC generated a net profit of 430 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DU PARC ?
The headquarters of SELARL PHARMACIE DU PARC is located in MAULEVRIER (49360), in the department Maine-et-Loire.
Where to find the tax return of SELARL PHARMACIE DU PARC ?
The tax return of SELARL PHARMACIE DU PARC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU PARC operate?
SELARL PHARMACIE DU PARC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart